O Brien Greene & Co. Inc lessened its stake in Aflac Incorporated (NYSE:AFL – Get Rating) by 66.7% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 4,825 shares of the financial services provider’s stock after selling 9,650 shares during the period. O Brien Greene & Co. Inc’s holdings in Aflac were worth $347,000 […]
O Brien Greene & Co. Inc acquired a new stake in Genuine Parts (NYSE:GPC – Get Rating) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,173 shares of the specialty retailer’s stock, valued at approximately $203,000. Other hedge funds and other institutional […]
O Brien Greene & Co. Inc bought a new position in shares of iShares GSCI Commodity Dynamic Roll Strategy ETF (NASDAQ:COMT – Get Rating) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 9,030 shares of the company’s stock, valued at […]
O Brien Greene & Co. Inc trimmed its position in Crown Castle Inc. (NYSE:CCI – Get Rating) by 67.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,046 shares of the real estate investment trust’s stock after selling 4,188 shares during the […]
O Brien Greene & Co. Inc reduced its position in Eli Lilly and Company (NYSE:LLY – Get Rating) by 67.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 940 shares of the company’s stock after selling 1,925 shares during […]